Vanguard Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
Other funds holding FENC
ACM
AIC
PCA
Vanguard Capital Management's FENC Position: Q3 2026 in Review
Vanguard Capital Management held its Fennec Pharmaceuticals (FENC) position steady in Q3 2026 at 839,306 shares worth $8.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2824.
Vanguard Capital Management first reported a position in FENC in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.02M in Q2 2026. 118 funds tracked by Wall St. Rank hold FENC as of Q3 2026.
- Vanguard Capital Management held 839,306 shares of Fennec Pharmaceuticals worth $8.94M as of Q3 2026.
- Vanguard Capital Management left its Fennec Pharmaceuticals share count unchanged in Q3 2026.
- Fennec Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2824 holding.
- Vanguard Capital Management first reported a position in Fennec Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Fennec Pharmaceuticals position peaked at $9.02M in Q2 2026.
- 118 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.